SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Provectus Pharmaceuticals Inc.
An SI Board Since April 2006
Posts SubjectMarks Bans Symbol
13111 103 0 PVCT
Emcee:  Jack Russell Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12236I don't give a flying f through a rolling donut about your peer reviewed toiMimbari-7/16/2013
12235A wonderful rumor that has not been substantiated in any peer reviewed arena.NTTG17/16/2013
12234I understood it was not your list. several PII and small series studies have loNTTG17/15/2013
12233For the record, pv-10 is the only cytotoxic out there that is toxic to just cancMimbari27/15/2013
12232This is not my list. It is the list covered by Dr Andtbacka in March of this yeamplaut-7/15/2013
12231Hmmmm. If I did not know better I think NTTG just made a point for PVCT. Thank yMimbari-7/15/2013
12230Which of those agents are directly cytotoxic to tumor cells? Answer: one, RB WNTTG17/15/2013
12229According to Dr Robert Andtbacka in his "Current Status of Injectable Theramplaut-7/15/2013
12228Link to an excellent article about clinical trials posted by LurkeyTurkey on InvHoward Williams-7/15/2013
12227You might want to think about reading the poster before responding...the tables NTTG17/13/2013
12226Pvct wanted to have stage IV patients, the FDA said not necessary in their case.Mimbari27/13/2013
12225Did you see how good those response rates were? Yes they are lower in the Stage Mimbari17/13/2013
12224You must be joking, have you ever been to the company website before? Read the NTTG17/13/2013
12223Please provide a detailed analysis on the PIII dataset as you claim. A simple stMimbari-7/13/2013
12222Analysis of the PIII dataset available in the public domain demonstrated signifiNTTG17/13/2013
12221NTTG: Not being a pain in the A; But, can you explain why they are not in a posidirkdiggler-7/12/2013
12220Fact sheet is also updated.libertykid-7/12/2013
12219On their Website the Press Kit is date 7-11-13.libertykid-7/12/2013
12218Yes, can't figure it out either. Must have received 8 of them today.Littlebits-7/11/2013
12217Nope.Mimbari-7/11/2013
12216Provectus IR app is constantly sending me notices, but there is nothing new. AnyKhris Smith-7/11/2013
12215pharmupdates.wordpress.com the author - a pharma student - is wrong about phasjm2i123-7/11/2013
12214I was kidding but will not go out looking for murine if I get redeye. You areprvtinvest17/10/2013
12213Actually, ophthalmologists have moved away from using RB for corneal evaluation,NTTG17/10/2013
12212Come on NTTG, everyone knows Murine is best for red eye!!!!! What we are lookinprvtinvest-7/10/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News